Mechanisms of disease: Detrimental adrenergic signaling in acute decompensated heart failure

Nature Clinical Practice Cardiovascular Medicine

Volumn 5, Issue 4, 2008, Pages 208-218

  Feldman, David S ^a   Elton, Terry S ^a   Sun, Benjamin ^a   Martin, Mickey M ^a   Ziolo, Mark T ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; G PROTEIN COUPLED RECEPTOR; INOTROPIC AGENT; LOOP DIURETIC AGENT; MORPHINE SULFATE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RYANODINE RECEPTOR; VASODILATOR AGENT;

ACUTE HEART FAILURE; ADRENERGIC ACTIVITY; ADRENERGIC STIMULATION; APOPTOSIS; CALCIUM CURRENT; CALCIUM TRANSPORT; CELL DEATH; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; EXCITATION CONTRACTION COUPLING; HEART DEPOLARIZATION; HEART MUSCLE CONTRACTILITY; HOSPITALIZATION; HUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ACUTE DISEASE; HEART FAILURE; HUMANS; PROGNOSIS; RECEPTORS, ADRENERGIC; SIGNAL TRANSDUCTION;

EID: 41549118544     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio1127     Document Type: Review

References (76)

1. Heart Failure Society of America (2006) HFSA 2006 Comprehensive heart failure practice guideline. J Card Fail 12: E1-2
2. Tilley DG and Rockman HA (2006) Role of β-adrenergic receptor signaling and desensitization in heart failure: New concepts and prospects for treatment. Expert Rev Cardiovasc Ther 4: 417-432
3. Feldman DS et al. (2005) Mechanisms of disease: β-adrenergic receptors - alterations in signal transduction and pharmacogenomics in heart failure. Nat Clin Pract Cardiovasc Med 2: 475-483
4. Jong P et al. (2002) Prognosis and determinants of survival in patients newty hospitalized for heart failure: A population-based study. Arch Intern Med 162: 1689-1694
5. Feldman D et al. (2007) Management strategies for stage-d patients with acute heart failure. Clin Cardiol [doi:10.1002/olc.20251]
6. Doughty RN et al. (1997) Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia - New Zealand Heart Failure Research Collaborative Group. J Am Coll Cardiol 29: 1060-1066
7. CIBIS-II Investigators and Committees (1999) The Cardiac Insufficiemcy Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 353 9-13
8. MERIT-HF Study Group (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353: 2001-2007
9. Packer M et al. (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med 334: 1349-1355
10. Lohse MJ et al. (2003) What is the role β-adrenergic signaling in heart failure? Circ Res 93: 896-906
11. Vatner SF et al. (2000) β-Adrenergic receptor signaling: An acute compensatory adjustment-inappropriate for the chronic stress of heart failure? Insights from Gsalpha overexpression and other genetically engineered animal models. Circ Res 86: 502-506
12. Bristow MR et al. (1990) β-Adrenergic pathways in nonfailing and failing human Ventricular myocardium. Circulation 82 (2 Suppl) 112-125
13. Rajagopal K et al. (2006) β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes. Proc Natl Acad Sci USA 103: 16284-16289
14. Noma T et al. (2007) β-Arrestin-mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection. J Clin Invest 117: 2445-2458
15. Ojeda S et al. (2005) Short- and long-term results of a programme for the prevention of readmissions and mortality in patients with heart failure: Are effects maintained after stopping the programme? Eur J Heart Fail 7: 921-926
16. Lefkowitz RJ (1993) G protein-coupled receptor kinases. Cell 74 409-412
17. laccarino G et al. (2005) Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Eur Heart J 26 1752-1758
18. Luttrell LM et al. (1999) β-Arrestin-dependent formation of β2 adrenergic receptor-Src protein kinase complexes. Science 283 655-661
19. Dent MR et al. (2007) Alterations in both death and survival signals for apoptosis in heart failure due to volume overload. J Mol Cell Cardiol 43: 726-732
20. Muraski JA et al. (2007) Pirn- 1 regulates cardiomyocyte survival downstream of Akt. Nat Med 13: 1467-1475
21. Singh K et al. (2001) Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol 189: 257-265
22. Beltrami CA et al. (1994) Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 89: 151-163
23. Communal C and Colucci WS (2005) The control of cardiomyocyte apoptosis via the β-adrenergic signaling pathways. Arch Mal Coeur Vaiss 98: 236-241
24. Wencker D et al. (2003) A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111: 1497-1504
25. Xiang Y and Kobilka BK (2003) Myocyte adrenoceptor signaling pathways. Science 300: 1530-1532
26. Beltrami CA et al. (1995) The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol 27: 291-305
27. Olivetti G et al. (1997) Apoptosis in the failing human heart. N Engl J Med 336: 1131-1141
28. Narula J et al. (1996) Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335: 1182-1189
29. Rossig L et al. (2000) Congestive heart failure induces endothelial cell apoptosis: Protective role of carvedilol. J Am Coll Cardiol 36: 2081-2089
30. Chang J et al. (2006) Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage playsan essential role in cardiac myocyte apoptosis. Proc Natl Acad Sci USA 103: 14495-14500
31. Cardone MH et al. (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-1321
32. Mallat Z et al. (1996) Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 335: 1190-1196
33. Bing OH (11994) Hypothesis: Apoptosis maybe a mechanism for the transition to heart failure with chronic pressure overload. J Mol Cell Cardiol 26: 943-948
34. Kitsis RN and Mann DL (2005) Apoptosis and the heart: A decade of progress. J Mol Cell Cardiol 38: 1-2
35. Communal C et al. (2002) Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci USA 99: 6252-6256
36. Narula J et al. (2001) Apoptosis and the systolic dysfunction in congestive heart failure: Story of apoptosis interruptus and zombie myocytes. Cardiol Clin 19: 113-126
37. Chandrashekhar Y et al. (2904) Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J Am Coll Cardiol 43: 295-301
38. Laugwitz KL et al. (2001) Blocking caspase-activated apoptosis improves contractility in failing myocardium. Hum Gene Ther 12 2051-2063
39. Bers DM (2001) Excitation-Contraction Coupling and Cardiac Contractile Force. Dordrecht: Kluwer Academic Publishers
40. Ziolo MT et al. (2005) Adenoviral gene transfer of mutant phospholamban rescues contractile dysfunction in failing rabbit myocytes with relatively preserved SERCA function. Circ Res 96: 815-817
41. Piacentino V III et al. (2003) Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ Res 92 651-658
42. Maier LS et al. (2006) Dynamic changes in free Ca - calmodulin levels in adult cardiac myocytes. J Mol Cell Cardiol 41: 451-458
43. Curran J et al. (2007) β-Adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase. Circ Res 100: 391-398
44. Kohlhaas M et al. (2006) Increased sarcoplasmic reticulum calcium leak but unaltered contractility by acute CaMKII overexpression in isolated rabbit cardiac myocytes. Circ Res 98: 235-244
45. Bassani JW et al. (1995) Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am J Physiol 266: C1313-C1319
46. Pogwizd SM et al. (2001) Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual β-adrenergic responsiveness. Circ Res 88: 1159-1167
47. Venetucci LA et al. (2007) Increasing ryanodine receptor open probability alone does not produce arrhythmogenic calcium waves: threshold sarcoplasmic reticulum calcium content is required. Circ Res 100: 105-111
48. Wagner S et al. (2006) Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels. J Clin Invest 116: 3127-3138
49. Olshansky B et al. (2007) Where patients with mild to moderate heart failure die: Results from the Sudden Cardiac Death In Heart Failure Trial (SCD-HeFT). Am Heart J 153: 1089-1094
50. Srivastava S et al. (2007) Downregulation of CuZnsuperoxide dismutase contributes to β-adranegic receptor-mediated oxidative stress in the heart. Cardiovasc Res 74: 445-455
51. Baumgarten G et al (2002) Load-dependent and -independent regulation of proinflammatory oytokine and cytokine receptor gene expression in the adult mammalian heart. Circulation 108: 2192-2197
52. Niebauer J et al. (1999) Exdotoxin and immune activation in chronic heart failure: A prospective cohort study. Lancet 353 1838-1842
53. Suzuki H et al. (2005) Time-course of changes in the levels of interleukin 6 in acutely decompensated heart failure. Int J Cardiol 100: 415-420
54. Csont T et al. (2005) The involvement of superoxide and iNOS-derived NO in cardiac dysfunction induced by pro-inflammatory cytokines. J Mol Cell Cardiol 39: 833-840
55. 2. Am J Physiol 274: H416-H423
56. Zeitz O et al. (2002) Hydroxyl radical-induced acute diastolic dysfunction is due to calcium overload via reverse-mode Na(+)-Ca(2+) exchange. Circ Res 90: 988-995
57. Xu KY et al. (1997) Hydroxyl radical inhibits sarcoplasmic reticulum Ca(2+)-ATPase function by direct attack on the ATP binding site. Circ Res 80: 76-81
58. Goldhaber JI (1996) Free radicals enhance Na+/Ca2+ exchange in ventricular myocytes. Am J Physiol 271: H823-H833
59. Zima AV et al. (2004) Effects of cytosolic NADH/NAD(+) levels on sarcoplasmic reticulum Ca(2+) release in pemeabilized rat ventricular myocytes. J Physiol 555: 727-741
60. Song Y et al. (2006) Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther 318: 214-222
61. Ziolo MT and Bers DM (2003) The real estate of NOS signaling: Location, location, location. Circ Res 92: 1279-1281
62. Ziolo MT et al. (2001) Myocytes isolated from rejecting transplanted rat hearts exhibit a nitric oxide-mediated reduction in the calcium current. J Mol Cell Cardiol 33, 1691-1699
63. Hu A et al. (2006) Chronic β-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischemia/reperfusion injury by provoking inducible nitric-oxide synthase-mediated nitrative stress. J Pharmacol Exp Ther 318: 469-475
64. Oddis CV et al. (1995) cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes. Am J Physiol 269 H2044-H2050
65. Ziolo MT et al. (2001) Expression of inducible nitric oxide synthase depresses β-adrenergic-stimulated calcium release from the sarcoplasmic reticulum in intact ventricular myocytes. Circulation 104: 2961-2966
66. Ziolo MT et al. (2004) Myocyte nitric oxide synthase 2 contributes to blunted β-adrenergic response in failing human hearts by decreasing Ca2+ transients. Circulation 109: 1886-1891
67. Kohr MJ et al.: Targeting of phospholamban by peroxynitrite decreases β-adrenergic stimulation in cardiomyocytes. Cardiovasc Res in press
68. Adam L et al. (1999) Nitric oxide modulates β(2)-adrenergic receptor palmitoylation and signaling. J Biol Chem 274: 26337-26343
69. Saraiva RM et al. (2005) Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: Role of nitroso-redox equilibrium. Circulation 112 3415-3422
70. Buys ES et al. (2007) Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload. Am J Physiol Heart Circ Physiol 293 H620-H627
71. Damy T et al. (2004) Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet 363: 1365-1367
72. Bendall JK et al. (2004) Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in β-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat. Circulation 110: 2368-2375
73. Whalen, EJ et al. (2007) Regulation of β-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell 129: 511-522
74. Hare JM and Stamler JS (2005) NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest 115: 509-517
75. Kubalova Z et al. (2005) Abnormal intrastore calcium signaling in chronic heart failure. Proc Natl Acad Sci USA 102: 14104-14109
76. Nishijima Y et al. (2007) Chronic cardiac resynchronization therapy and reverse ventricular remodeling in a model of nonischemic cardiomyopathy. Life Sci 81: 1152-1159